Home » Topics » Hematologic, BioWorld Science

Hematologic, BioWorld Science
RSS

ConjuChem terminates DAC:TI development

Aug. 13, 2002

Novel thrombin inhibitors in Merck & Co. pipeline

Aug. 12, 2002

Inspire and Discovery collaborate on P2Y12 antagonist program for cardiovascular disease

Aug. 9, 2002

Factor Xa/factor VIIa inhibitors reported by Aventis

Aug. 8, 2002

New factor Xa/factor VIIa inhibitors in early development at Merck

Aug. 5, 2002

Potential new therapeutic agent for arterial thrombosis discovered in Taiwan

Aug. 5, 2002

Novel antithrombin agents prepared and tested at Servier

Aug. 2, 2002

Bivalirudin + abciximab for percutaneous coronary revascularization

Aug. 2, 2002

Aventis describes novel factor Xa/VIIa inhibitors and their use

Aug. 1, 2002

Arixtra launched in Germany for preventing VTEs

July 31, 2002

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 29, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 30, 2026
CINP 2026: Gut microbiota could predict antidepressant response
BioWorld
The gut microbiota may be altered in people with depression as a result of treatment. These microorganisms reorganize differently in individuals who respond to...
Ascending BCI systems deepen national security, ethical concerns
BioWorld
Ready or not, the future has arrived. Novel AI and brain-computer interface (BCI) systems are no longer confined to the realm of science fiction. As an...
Deerfield-backed Boulevard, Metis pen $1.6B trispecific TCE deal
BioWorld
A U.S. biotechnology company founded by Deerfield Management Company L.P. licensed exclusive rights to Metis Techbio Co. Ltd.’s preclinical trispecific T-cell...